Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Alerian Disruptive Technology Real Estate UCITS ETF 08.07.2026 LANDXN.LN IE000RN036E0 34,035.00 USD 741,719.38 21.793  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 08.07.2026 METL LN IE000UDFKE13 175,002.00 USD 5,945,187.99 33.972  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Indxx Innovative Transaction & Process UCITS ETF 08.07.2026 LEGR LN IE00BF5DXP42 950,002.00 USD 50,225,013.20 52.868  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 08.07.2026 QCLN.LN IE00BDBRT036 2,300,002.00 USD 48,621,569.24 21.140  ...

INDIANAPOLIS & NEW ALBANY, Ind.--(BUSINESS WIRE)--Anthem Blue Cross and Blue Shield has joined forces with One Southern Indiana (1si) to help small businesses provide their employees with lower cost, high-quality health benefits through the new Advantage 1 Health program, a Multiple Employer Welfare Arrangement (MEWA). Designed exclusively for members of 1si and participating local chambers of commerce, the program enables small employers to provide big company benefits at lower, more predictab...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 08.07.2026 SDVI.LN IE000YVOQ2A3 40,361.00 USD 1,160,319.74 28.749  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust SMID Rising Dividend Achievers UCITS ETF 08.07.2026 SDVY.LN IE0001R850E1 15,154,007.00 USD 384,451,393.20 25.370  ...

BENGALURU, India & BRIDGEWATER, N.J.--(BUSINESS WIRE)--Biocon Limited (BSE: 532523; NSE: BIOCON), an innovation‑led global biopharmaceutical company, today announced the publication of two important clinical studies supporting the effectiveness of Yesafili™ (aflibercept-jbvf). The clinical data from the Phase III INSIGHT program evaluating MYL‑1701P, its aflibercept biosimilar, was published in two peer-reviewed journals, contributing to the clinical evidence base supporting the development of...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Growth Strength UCITS ETF 08.07.2026 FTGS.LN IE000YZLMXT9 25,002.00 USD 589,038.38 23.560  ...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - February 08.07.2026 GFEB.LN IE000X8M8M80 700,002.00 USD 27,496,089.30 39.280  ...